Clinical Research

Teva Branded Pharmaceutical Products R&D LLC

Address
145 Brandywine Parkway

Sponsor Overview

assignment
12
sponsored trials
science
6
molecules
location_city
238
research centres
public
19
countries
person_search
268
investigators

Specializations

Inflammatory Bowel Disease

Clinical research in ulcerative colitis and Crohn’s disease is a major focus, with attention to disease control, mucosal healing, and maintenance of remission in adults with moderate to severe inflammatory bowel disease.

  • Ulcerative colitis
  • Crohn’s disease
  • Clinical remission
  • Endoscopic response

These studies reflect interest in both induction and longer-term management of intestinal inflammation.

Respiratory Disease

The sponsor supports trials in asthma, including evaluation of rescue and maintenance treatment strategies for patients with persistent airway disease and related exacerbations.

  • Asthma
  • Rescue medication
  • Severe exacerbations
  • Airway inflammation

Research activity in this area centers on symptom prevention and control of acute respiratory worsening.

Neurology and Movement Disorders

Neurological research includes multiple system atrophy and migraine, with a focus on long-term tolerability, preventive treatment, and symptom reduction across adult and pediatric populations.

  • Multiple system atrophy
  • Migraine prevention
  • Pediatric participants
  • Chronic neurologic symptoms

These programs span both rare neurodegenerative disease and recurrent headache disorders.

Gastrointestinal and Immune-Mediated Conditions

Additional work addresses celiac disease and pruritus, extending the sponsor’s interest in immune-linked gastrointestinal disorders and symptom burden associated with inflammatory conditions.

  • Celiac disease
  • Gluten-induced enteropathy
  • Pruritus
  • Immune-mediated disease

These studies include both disease-specific and symptom-focused therapeutic areas.

Psychiatry and Healthy Participant Research

The portfolio also includes schizophrenia and studies in healthy participants, supporting work on psychiatric treatment exposure and foundational pharmacologic characterization.

  • Schizophrenia
  • Healthy participants
  • Pharmacokinetics
  • Drug absorption and metabolism

These trials broaden the sponsor’s therapeutic scope beyond disease-specific treatment into psychiatric and early human research settings.

Sponsored Trials

Trial Name Country Status
Comparative Bioavailability Study of TV-44749 Versus Oral Olanzapine in Schizophrenia PatientsCroatia CroatiaFrance FranceGermany GermanySpain SpainNot Yet Recruiting
Efficacy and Safety Evaluation of Fluticasone Propionate/Salbutamol Sulfate Combination in Asthma Patients Aged 12 and Older: A Randomized, Double-Blind, Placebo-Controlled TrialBulgaria BulgariaCzechia CzechiaGermany GermanyPoland PolandRomania RomaniaSlovakia SlovakiaRecruiting
Efficacy and Safety Evaluation of TEV-53408 in Adults with Celiac Disease Undergoing Oral Gluten Challenge: A Phase 2a Randomized, Double-Blind, Placebo-Controlled TrialFinland FinlandNot Recruiting
Evaluation of Long-Term Efficacy and Safety of TEV-48574 in Adults with Moderate to Severe Ulcerative Colitis or Crohn's DiseaseAustria AustriaBulgaria BulgariaCzechia CzechiaGermany GermanyHungary HungaryItaly ItalyNorway NorwayPoland PolandSlovakia SlovakiaSpain SpainNot Recruiting
Evaluation of TEV-48574 (Duvakitug) in Adults with Moderate to Severe Ulcerative Colitis or Crohn's Disease: A Randomized, Double-Blind, Dose-Ranging StudyAustria AustriaBelgium BelgiumBulgaria BulgariaCzechia CzechiaFrance FranceGermany GermanyHungary HungaryItaly ItalyNorway NorwayPoland PolandSlovakia SlovakiaSpain SpainNot Recruiting
Evaluation of the Efficacy and Safety of Fluticasone Propionate/Salbutamol Sulfate in Reducing Severe Asthma Exacerbations in Asthma PatientsBulgaria BulgariaCzechia CzechiaDenmark DenmarkGermany GermanyGreece GreeceHungary HungaryItaly ItalyLatvia LatviaPoland PolandRomania RomaniaSlovakia SlovakiaSpain SpainNot Recruiting
Long-Term Safety, Tolerability, and Efficacy of Fremanezumab in Pediatric Episodic and Chronic Migraine: A Multicenter, Open-Label StudyFinland FinlandGermany GermanyItaly ItalyPoland PolandSpain SpainThe Netherlands The NetherlandsNot Recruiting
Mass Balance Study of [14C]-TEV-56286 Absorption, Metabolism, and Excretion in Healthy Male Subjects Following Multiple Doses of Nonlabeled TEV-56286.The Netherlands The NetherlandsNot Recruiting
Pharmacodynamic Evaluation of TEV-56192 in a Double-Blind, Randomized, Placebo-Controlled Phase 1b Trial for Pruritus in Healthy SubjectsDenmark DenmarkNot Recruiting
Phase 2 Open-Label Extension Study to Evaluate the Safety and Efficacy of Emrusolmin in Adults with Multiple System AtrophyFrance FranceGermany GermanyItaly ItalySpain SpainRecruiting
1–10 of 12
1 / 2

Data & Insights

science
Molecule Portfolio
Compounds under investigation
2
Exclusive Molecules
out of 6 total (33% not shared with other sponsors)

This sponsor works with 6 molecules, of which 2 are not being studied by other sponsors.

hub
Site Partnerships
Collaboration with research centres
37%
Return partnership rate
88 of 238 sites collaborated multiple times

This sponsor has worked with 238 sites across their trial portfolio.

Therapeutic Focus

  • 1.
    Digestive System Diseases4 trials
    280 other sponsors
  • 2.
    Nervous System Diseases4 trials
    449 other sponsors
  • 3.
    Respiratory Tract Diseases2 trials
    277 other sponsors
  • 4.
    Mental Disorders1 trial
    150 other sponsors
  • 5.
    Skin and Connective Tissue Diseases1 trial
    247 other sponsors

Partnered Research Centres

238 centres
location_city
assignment335
Aalborg University Hospital
Address
Hobrovej 18-22, 9000 Aalborg
Learn morearrow_forward
location_city
assignment36
Acibadem City Clinic University Multiprofile Hospital For Active Treatment EOOD
Address
Bulevard Tsarigradsko Shose 66a, 1784 Sofia
Learn morearrow_forward
location_city
assignment2
AGPSMP Pediatric Diseases South Park OOD
Address
110, Dimitar Hadjikotzev str., 1421 Sofia
Learn morearrow_forward
location_city
assignment185
Akershus University Hospital
Address
Sykehusveien 25, 1474 Lorenskog
Learn morearrow_forward
location_city
assignment28
Alergo Med Osrodek Badan Klinicznych Sp. z o.o.
Address
Ul. Polskiego Czerwonego Krzyza 26, 33-100 Tarnow
Learn morearrow_forward
location_city
assignment10
AlergoImuno centrum s.r.o.
Address
Hradska Cesta 2, 060 01 Kežmarok
Learn morearrow_forward
Page 1 of 40

Want to get in touch with this sponsor?

Send a question and we'll pass it on to Teva Branded Pharmaceutical Products R&D LLC.

Need a custom report on this sponsor?

Competitive positioning, market entry, partnership opportunities — tell us the question.

Is something out of date?

Tell us what needs correcting and we'll update this profile.